This website isn’t supported by Internet Explorer. We recommend that you use a different browser (e.g. Edge, Chrome, Firefox, Safari, or similar) for the best experience of our content.
/ / /
/ / /

For healthcare professionals only

You are viewing the Novo Nordisk Virtual platform, provided to non-US health care professionals from around the world. By accessing this site and materials you accept this legal notice and expressly confirm your status as a healthcare professional.

 

This site is not country-specific and therefore may contain information which is not applicable to your country. Therefore, before prescribing any product, always refer to local materials such as the prescribing information and/or the Summary of Product Characteristics.

 

This site is not intended to provide medical advice and/or treatment guidance. Novo Nordisk accepts no liability for the accuracy, completeness or use of the information, and disclaims any liability to update the information contained on this site.

I hereby declare I am a non-US health care professional and that I have read and agreed to the terms mentioned above.

Obesity and CVD

Explore the link between obesity and cardiovascular disease (CVD) and the global burden of CVD.

 

Learn more about obesity and CVD 

Obesity and CVD

Explore the link between obesity and cardiovascular disease (CVD) and the global burden of CVD.

 

Learn more about obesity and CVD 

A century of breakthroughs in health has shown us that progress is only made possible by driving change. As Novo Nordisk turns 100, we renew our commitment to drive change for a healthy world today, and for generations to come. 

 

We invite you to explore our heritage and the legacy of our founders which have characterised our past and will define our future.

 

Learn more

1.

Tsao et al. Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association. Circulation. 2023;147:e93–e621.

2.

World Obesity Federation. World Obesity Atlas 2023. Available at: https://www.worldobesity.org/resources/resource-library/world-obesity-atlas-2023 Last accessed: June 2023.

3.

Yuen M. ER, Kadambi N. A systematic review and evaluation of current evidence reveals 236 obesity-associated disorders. The obesity society 20167

4.

World Health Organisation (WHO). Cardiovascular diseases (CVDs) factsheet. 2022. Available at: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds). Last Accessed: June 2023

5.

Institute for Health Metrics and Evaluation (IHME). GBD Compare. Viz Hub. 2022. Available at: https://www.healthdata.org/results/gbd_summaries/2019/cardiovascular-diseases-level-2-cause Last Accessed: June 2023

FOR HEALTHCARE PROFESSIONALS ONLY

 

The information contained in this site is intended for healthcare professionals only outside of the United States of America. This site is not intended to provide medical advice and/or treatment guidance. Only a physician can determine whether a specific product is correct for a particular patient. This site is not country-specific and therefore may contain information which is not applicable to your country. Novo Nordisk accepts no liability for the accuracy, completeness or use of this information, and disclaims any liability to update the information contained on this site. By accessing this site and materials you accept this legal notice and expressly confirm your status as a healthcare professional. Any images shown are models and not real patients.

 

▼ This medicinal product is subject to additional monitoring, reporting of suspected adverse reactions associated with this medicinal product is a priority.

 

 

HQ24CARD00002, February 2024